Axsome Therapeutics, Inc.

AXSM

Axsome Therapeutics, Inc.

AXSM

Insider Sentiment (TTM):

Last Purchase:2025-09-08Last Sale:2026-06-11Shares Purchased (TTM):1,575Shares Sold (TTM):461,495

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:36,033,901Shares Outstanding:51,198,349Institutional Ownership Pct.:70.38%

Earnings Market Reaction:

Filing Date:2026-05-04Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Axsome Therapeutics, Inc. (AXSM) — SEC Financial Statements & Analysis

Axsome Therapeutics, Inc. (AXSM) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	305	323	325	303	301	315	327	316	331	386	417	437
Accounts Receivable Net Current	251	224	197	199	161	142	124	120	101	95	78	67
Inventory Net	32	28	24	18	16	16	14	15	16	15	10	9
Prepaid Expense And Other Assets Current	24	14	20	16	16	12	13	12	12	8	7	6
Assets Current	611	589	565	537	495	485	479	463	460	504	512	520
Property Plant And Equipment Net	1	1	1	1	1	1	1	1	1	1	1	1
Operating Lease Right Of Use Asset	20	21	22	22	23	5	6	6	6	7	7	7
Goodwill	12	12	12	12	12	12	12	12	12	12	12	12
Intangible Assets Net Excluding Goodwill	39	41	42	44	45	47	49	50	52	53	55	57
Other Inventory Noncurrent	31	27	27	24	21	19	15	16	14	11	14	15
Assets	714	690	669	640	597	568	561	548	546	588	601	612
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	107	66	54	92	86	72	64	61	54	41	29	43
Accounts Payable And Other Accrued Liabilities Cur…	251	233	226	171	149	148	122	117	83	91	78	65
Operating Lease Liability Current	1	0	1	0	0	2	2	1	1	1	0	0
Business Combination Contingent Consideration Liab…	11	10	10	9	9	8	8	7	6	6	7	6
Long Term Debt Current	70	70	70	70	-	0	-	-	-	-	-	-
Liabilities Current	439	379	360	342	244	230	196	187	144	139	115	115
Business Combination Contingent Consideration Liab…	74	78	90	80	91	92	83	70	70	73	32	34
Long Term Debt Noncurrent	118	118	118	118	181	181	180	179	179	178	177	177
Operating Lease Liability Noncurrent	22	23	23	24	24	6	6	7	7	7	8	8
Finance Lease Liability Noncurrent	6	4	5	4	4	3	3	3	2	-	-	-
Liabilities	659	602	596	567	543	511	469	445	402	397	331	333
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,425	1,394	1,351	1,303	1,235	1,180	1,141	1,086	1,048	1,027	1,006	954
Retained Earnings Accumulated Deficit	-1,371	-1,306	-1,277	-1,230	-1,182	-1,123	-1,048	-983	-904	-836	-737	-675
Stockholders Equity	55	88	74	73	53	57	93	103	144	191	270	279
Liabilities And Stockholders Equity	714	690	669	640	597	568	561	548	546	588	601	612
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	150	150	150	150	150	150	150	150	150	150	150	150
Common Stock Shares Issued	51	51	50	50	49	49	48	48	47	47	47	47
Shares Outstanding	51	51	50	50	49	49	48	48	47	47	47	47

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	4.82%	8.03%	-	-	-	-	-	-	-	-	-	-
2025	-9.73%	-11.27%	-13.44%	13.84%	9.59%	21.60%	11.60%	12.01%	36.99%	-10.21%	8.14%	30.30%
2024	-3.31%	6.00%	13.95%	6.79%	7.73%	8.00%	0.61%	-13.11%	7.01%	-4.82%	-23.44%	-15.87%
2023	-3.41%	-6.36%	2.53%	14.91%	-1.69%	-12.67%	8.94%	27.51%	43.93%	-4.31%	-12.40%	-8.16%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.39	1.55	1.57	1.57	2.03	2.11	2.44	2.48	3.20	3.63	4.46	4.52
Quick Ratio	1.27	1.44	1.45	1.47	1.90	1.99	2.30	2.34	3.01	3.46	4.32	4.39
Working Capital	172.00M	210.15M	205.05M	194.52M	250.72M	254.96M	282.93M	276.46M	316.44M	365.41M	397.10M	404.71M
Leverage & Debt
Debt to Equity	12.07	6.81	8.08	7.76	10.21	8.97	5.04	4.33	2.79	2.08	1.23	1.19
Debt Ratio	0.92	0.87	0.89	0.89	0.91	0.90	0.83	0.81	0.74	0.68	0.55	0.54
Efficiency & Turnover
Asset Turnover TTM	1.08	1.01	0.91	0.83	0.76	0.67	0.58	0.50	0.54	0.59	0.48	0.46
Days Sales Outstanding TTM	106.28	104.75	104.25	117.66	110.99	112.06	109.20	117.55	106.31	89.37	80.63	83.58
Receivables Turnover TTM	3.43	3.48	3.50	3.10	3.29	3.26	3.34	3.11	3.43	4.08	4.53	4.37
Per Share Metrics
Diluted EPS TTM	-3.68	-3.68	-4.59	-4.99	-5.69	-5.99	-6.46	-6.49	-6.25	-5.27	-4.28	-4.22
Free Cash Flow Per Share TTM	-1.39	-1.89	-2.03	-2.45	-2.43	-2.69	-2.76	-3.53	-4.08	-3.21	-3.04	-2.56
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	92.60%	92.56%	91.86%	91.48%	91.49%	91.37%	91.09%	90.30%	90.12%	90.37%	90.61%	91.03%
Operating Profit Margin TTM	-24.45%	-26.12%	-37.85%	-46.25%	-62.54%	-72.74%	-90.48%	-104.88%	-116.61%	-85.67%	-86.59%	-95.21%
Net Profit Margin TTM	-26.59%	-28.69%	-40.89%	-49.88%	-64.39%	-74.47%	-91.87%	-105.85%	-118.07%	-88.41%	-90.33%	-101.07%
Growth Metrics
Net Revenue Growth (1Y)	63.88%	65.55%	65.83%	69.83%	72.16%	42.53%	51.47%	59.73%	73.58%	440.80%	770.57%	1,969.08%
Net Income Growth (1Y)	-32.33%	-36.22%	-26.19%	-19.98%	-6.11%	20.05%	54.07%	67.28%	86.73%	27.84%	26.25%	23.03%
EPS Growth (1Y)	-35.41%	-38.57%	-28.96%	-23.01%	-8.95%	13.82%	50.79%	53.55%	71.48%	14.42%	11.74%	10.10%
Valuation Metrics
P/E TTM	-45.96	-49.60	-26.47	-20.90	-20.48	-14.11	-13.91	-12.41	-12.76	-15.11	-16.32	-17.01
P/B	158.53	102.90	82.40	70.63	107.13	71.10	46.57	37.23	26.26	18.93	12.22	11.26
P/S TTM	12.22	14.23	10.82	10.43	13.19	10.51	12.78	13.14	15.07	13.36	14.74	17.20
Market Cap	8.65B	9.09B	6.08B	5.16B	5.70B	4.05B	4.33B	3.83B	3.78B	3.62B	3.29B	3.14B
Enterprise Value	8.54B	8.95B	5.94B	5.05B	5.58B	3.92B	4.18B	3.69B	3.63B	3.41B	3.05B	2.88B
Calculated Values
Free Cash Flow TTM	-70.99M	-93.89M	-101.39M	-121.10M	-118.83M	-128.68M	-132.82M	-168.02M	-193.34M	-145.66M	-143.04M	-111.94M
Net Debt	-117.26M	-135.19M	-137.63M	-115.48M	-119.53M	-134.64M	-147.34M	-136.33M	-152.75M	-208.12M	-239.12M	-260.29M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-11Sale

Owner: Jeffs, Roger

Title: -

Shares: 286

Price/Share: $249.12

Value: $71,248.32

Shares Owned: 58,367

Relationship: Director

Ownership: Direct

2026-06-10Sale

Owner: Mahony, Susan

Title: -

Shares: 300

Price/Share: $246.18

Value: $73,854.00

Shares Owned: 829

Relationship: Director

Ownership: Direct

2026-06-10Sale

Owner: Coleman, Mark

Title: -

Shares: 643

Price/Share: $249.00

Value: $160,107.00

Shares Owned: 30,389

Relationship: Director

Ownership: Direct

2026-06-09Sale

Owner: Pizzie, Nick

Title: Chief Financial Officer

Shares: 33,000

Price/Share: $240.09

Value: $7,922,970.00

Shares Owned: 42,867

Relationship: Officer

Ownership: Direct

2026-06-09Sale

Owner: Tabuteau, Herriot

Title: Chief Executive Officer

Shares: 49,670

Price/Share: $241.01

Value: $11,970,966.70

Shares Owned: 7,229

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-11	Jeffs, Roger	Director	-	Direct	Sale	286	249.12	$71,248.32	58,367	4
2026-06-10	Mahony, Susan	Director	-	Direct	Sale	300	246.18	$73,854.00	829	4
2026-06-10	Coleman, Mark	Director	-	Direct	Sale	643	249.00	$160,107.00	30,389	4
2026-06-09	Pizzie, Nick	Officer	Chief Financial Officer	Direct	Sale	33,000	240.09	$7,922,970.00	42,867	4
2026-06-09	Tabuteau, Herriot	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Sale	49,670	241.01	$11,970,966.70	7,229	4
2026-06-02	Coleman, Mark	Director	-	Direct	Sale	5,537	223.39	$1,236,910.43	29,603	4
2026-05-05	Jacobson, Mark L.	Officer	Chief Operating Officer	Direct	Sale	233	228.18	$53,165.94	0	4
2026-04-22	Maizel, Ari	Officer	Chief Commercial Officer	Direct	Sale	7,500	182.42	$1,368,150.00	0	4
2026-02-26	Coleman, Mark	Director	-	Direct	Sale	25,000	161.11	$4,027,750.00	47,140	4
2026-02-26	Jacobson, Mark L.	Officer	Chief Operating Officer	Direct	Sale	35,378	161.88	$5,726,990.64	0	4
2026-02-02	Tabuteau, Herriot	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Sale	32,410	185.60	$6,015,296.00	7,229	4
2026-01-22	Pizzie, Nick	Officer	Chief Financial Officer	Direct	Sale	12,000	187.92	$2,255,040.00	42,588	4
2026-01-21	Maizel, Ari	Officer	Chief Commercial Officer	Direct	Sale	7,500	184.44	$1,383,300.00	0	4
2026-01-07	Tabuteau, Herriot	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Sale	31,261	170.38	$5,326,249.18	7,229	4
2025-12-31	Saad, Mark E	Director	-	Direct	Sale	37,577	165.18	$6,206,968.86	10,002	4
2025-12-04	Tabuteau, Herriot	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Sale	10,558	148.18	$1,564,484.44	7,229	4
2025-11-05	Tabuteau, Herriot	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Sale	21,775	134.49	$2,928,519.75	7,229	4
2025-10-08	Tabuteau, Herriot	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Sale	12,774	118.84	$1,518,062.16	7,229	4
2025-09-22	Jacobson, Mark L.	Officer	Chief Operating Officer	Direct	Sale	10,000	115.96	$1,159,600.00	0	4
2025-09-16	Tabuteau, Herriot	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Sale	19,719	114.19	$2,251,712.61	7,229	4
2025-09-16	Jacobson, Mark L.	Officer	Chief Operating Officer	Direct	Sale	45,783	115.21	$5,274,659.43	0	4
2025-09-08	Coleman, Mark	Director	-	Direct	Purchase	1,575	127.30	$200,497.50	48,212	4
2025-09-05	Saad, Mark E	Director	-	Direct	Sale	9,127	125.07	$1,141,513.89	10,002	4
2025-09-02	Jeffs, Roger	Director	-	Direct	Sale	13,464	123.68	$1,665,227.52	57,510	4
2025-08-29	Jeffs, Roger	Director	-	Direct	Sale	20,000	121.27	$2,425,400.00	70,974	4
2025-08-26	Jeffs, Roger	Director	-	Direct	Sale	20,000	120.03	$2,400,600.00	130,974	4
2025-06-23	Murdock, Hunter R.	Officer	General Counsel	Direct	Sale	6,014	100.12	$602,121.68	0	4
2025-06-18	Murdock, Hunter R.	Officer	General Counsel	Direct	Sale	7,500	100.90	$756,750.00	0	4
2025-06-09	Jacobson, Mark L.	Officer	Chief Operating Officer	Direct	Sale	25,000	110.44	$2,761,000.00	5,783	4
2025-05-28	Jacobson, Mark L.	Officer	Chief Operating Officer	Direct	Sale	20,000	103.45	$2,069,000.00	5,783	4
2025-05-28	Coleman, Mark	Director	-	Direct	Sale	3,750	103.43	$387,862.50	46,637	4
2025-05-20	Coleman, Mark	Director	-	Direct	Sale	3,000	107.49	$322,470.00	54,137	4
2025-02-14	Pizzie, Nick	Officer	Chief Financial Officer	Direct	Sale	3,000	131.07	$393,210.00	42,187	4
2024-09-11	Saad, Mark E	Director	-	Direct	Sale	11,016	91.31	$1,005,870.96	10,002	4
2024-08-09	Jacobson, Mark L.	Officer	Chief Operating Officer	Direct	Sale	47,739	84.26	$4,022,488.14	5,783	4
2024-05-29	Jacobson, Mark L.	Officer	Chief Operating Officer	Direct	Sale	7,910	74.31	$587,792.10	5,783	4
2024-05-29	Coleman, Mark	Director	-	Direct	Sale	5,248	75.14	$394,334.72	14,600	4
2024-04-01	Jacobson, Mark L.	Officer	Chief Operating Officer	Direct	Sale	24,662	77.24	$1,904,892.88	0	4
2024-03-15	Jeffs, Roger	Director	-	Direct	Sale	2,347	71.61	$168,068.67	120,756	4
2023-09-15	Coleman, Mark	Director	-	Direct	Sale	11,016	75.19	$828,293.04	25,097	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

70.38%

Inst. Shares: 36,033,901

Shares Outstanding: 51,198,349

2025-12-31

72.00%

Inst. Shares: 35,818,496

Shares Outstanding: 49,747,178

2025-09-30

71.26%

Inst. Shares: 35,647,810

Shares Outstanding: 50,021,851

2025-06-30

74.14%

Inst. Shares: 36,657,805

Shares Outstanding: 49,442,001

2025-03-31

73.68%

Inst. Shares: 36,009,977

Shares Outstanding: 48,871,163

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	36,033,901	51,198,349	70.38%
2025-12-31	35,818,496	49,747,178	72.00%
2025-09-30	35,647,810	50,021,851	71.26%
2025-06-30	36,657,805	49,442,001	74.14%
2025-03-31	36,009,977	48,871,163	73.68%
2024-12-31	36,065,081	47,914,253	75.27%
2024-09-30	37,528,995	48,140,519	77.96%
2024-06-30	40,188,180	47,573,229	84.48%
2024-03-31	37,611,360	47,393,563	79.36%
2023-12-31	38,020,262	45,425,212	83.70%
2023-09-30	37,408,009	47,117,196	79.39%
2023-06-30	35,230,704	43,669,820	80.68%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Axsome Therapeutics, Inc. (AXSM) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.